Carregant...
SAT-454 Isolated ACTH Deficiency Due to Pembrolizumab
Introduction Pembrolizumab, a humanized anti-programmed death -1 antibody has been used in the treatment of several malignancies with improved prognosis, but it has been associated with several immune related adverse effects, particularly endocrinopathy. We report a case of pembrolizumab induced iso...
Guardat en:
| Publicat a: | J Endocr Soc |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Endocrine Society
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6552007/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/js.2019-SAT-454 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|